Opus Genetics, Inc.
IRD
Revenue
1.11M
▼-599.00k▼-35.01%
3 Months ChangeAssets
44.83M
▼-7.01M▼-13.52%
3 Months ChangeLiabilities
4.20M
▼-1.59M▼-27.46%
3 Months ChangeFree Cash Flow
-6.80M
▼-3.18M▼-87.87%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-22
Form 8-K
ID: 0001140361-24-043915
2024-08-13
Form 10-Q
ID: 0001140361-24-037068
2024-08-13
Form 8-K
ID: 0001140361-24-036944
2024-06-13
Form 8-K
ID: 0001140361-24-030012
2024-05-10
Form 10-Q
ID: 0001140361-24-025481
2024-05-10
Form 8-K
ID: 0001140361-24-025476
2024-05-10
Form 8-K
ID: 0001140361-24-025329
2024-04-17
Form 8-K
ID: 0001140361-24-020320
2024-03-27
Form 8-K
ID: 0001140361-24-015624
2024-03-08
Form 8-K
ID: 0001140361-24-012128